Chinese expert consensus on hematologic malignancy karyotyping.
1/5 보강
Chromosomal karyotype analysis is crucial for diagnosing and managing hematologic malignancies, yet inconsistent protocols compromise reliability.
APA
Yang Z, Chen S, et al. (2026). Chinese expert consensus on hematologic malignancy karyotyping.. Clinica chimica acta; international journal of clinical chemistry, 578, 120507. https://doi.org/10.1016/j.cca.2025.120507
MLA
Yang Z, et al.. "Chinese expert consensus on hematologic malignancy karyotyping.." Clinica chimica acta; international journal of clinical chemistry, vol. 578, 2026, pp. 120507.
PMID
40721192
Abstract
Chromosomal karyotype analysis is crucial for diagnosing and managing hematologic malignancies, yet inconsistent protocols compromise reliability. To standardize practices, this consensus integrates international guidelines (WHO, ICC, ELN) with clinical expertise, providing evidence-based recommendations for specimen collection, cell culture, chromosome harvesting, banding techniques, karyotype analysis, and reporting. By establishing uniform operational standards, this initiative seeks to mitigate variability, improve detection rates, and support precision medicine in hematologic malignancies.
MeSH Terms
Humans; Hematologic Neoplasms; Karyotyping; China; East Asian People
같은 제1저자의 인용 많은 논문 (5)
- Analysis of the effect of neuroendoscopy-assisted microscopy in the treatment of Large (Koos grade IV) vestibular schwannoma.
- Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy.
- Early diagnosis of colorectal cancer using Cerenkov luminescence endoscopy: a pilot trial involving humans for the first time.
- The diagnostic and therapeutic challenges of pulmonary epithelioid trophoblastic tumor: A case report and literature review.
- Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.